Charles River Laboratories International, Inc. (CRL)

NYSE: CRL · IEX Real-Time Price · USD
199.62
+1.47 (0.74%)
Sep 22, 2023, 4:00 PM EDT - Market closed
0.74%
Market Cap 10.23B
Revenue (ttm) 4.18B
Net Income (ttm) 484.03M
Shares Out 51.27M
EPS (ttm) 9.43
PE Ratio 21.17
Forward PE 18.37
Dividend n/a
Ex-Dividend Date n/a
Volume 751,771
Open 196.07
Previous Close 198.15
Day's Range 192.40 - 202.78
52-Week Range 181.22 - 262.00
Beta 1.33
Analysts Buy
Price Target 237.10 (+18.78%)
Earnings Date Nov 1, 2023

About CRL

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provi... [Read more]

Sector Healthcare
IPO Date Jun 23, 2000
Employees 21,400
Stock Exchange NYSE
Ticker Symbol CRL
Full Company Profile

Financial Performance

In 2022, CRL's revenue was $3.98 billion, an increase of 12.31% compared to the previous year's $3.54 billion. Earnings were $486.23 million, an increase of 24.36%.

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for CRL stock is "Buy." The 12-month stock price forecast is $237.1, which is an increase of 18.78% from the latest price.

Price Target
$237.1
(18.78% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Here are the 13 stocks Jim Cramer is watching, including Amazon, Oracle and Nike

Here are some of the tickers on my radar for Friday, Sept. 22, taken directly from my reporter's notebook.

1 day ago - CNBC

Charles River Laboratories to Host Virtual Investor Day

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CRL--Charles River Laboratories to Host Investor Day on September 21, 2023.

3 days ago - Business Wire

Charles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica

WILMINGTON, Mass. & DENVER--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River and Related Sciences announced a multi-program collaboration to apply Logica across several previously undrugged targets.

9 days ago - Business Wire

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CRL--Charles River Laboratories to Present at September Conferences.

12 days ago - Business Wire

Charles River and PathoQuest Announce Publication of a Head-to-Head Study Validating Proprietary Next Generation Sequencing Viral Safety Assay as a Reliable In Vitro Alternative to Animal Testing Methods

WILMINGTON, Mass. & PARIS--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and PathoQuest SAS, a leader in the development and provision of next-generation sequencing (NGS)...

17 days ago - Business Wire

Thailand's Government Pension Fund Selects Charles River for Managing Their Front Office Operations

BANGKOK--(BUSINESS WIRE)-- #assetowner--Thailand's Government Pension Fund (GPF) has selected Charles River IMS to modernise their front office operations.

25 days ago - Business Wire

Charles River Lab signs joint agreement for protection of crabs used in medical tests

Charles River Laboratories has signed a joint agreement with four entities to enhance protections in South Carolina for horseshoe crabs and a bird that feeds on their eggs, they said on Thursday.

4 weeks ago - Reuters

Charles River Laboratories Announces Plasmid Manufacturing Collaboration with Fondazione Telethon

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL), today announced a High Quality (HQ) plasmid manufacturing collaboration with Fondazione Telethon. The ra...

4 weeks ago - Business Wire

CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Charles River Laboratories International, In...

4 weeks ago - Business Wire

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Charles River Laboratories International, Inc. (NYSE: CRL)

NEW YORK , Aug. 21, 2023 /PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Charles River Laboratories International, Inc. (NYSE: CRL) concerning possible breaches of...

4 weeks ago - PRNewsWire

Charles River beats quarterly estimates on firm demand for drug discovery services

Charles River Laboratories International beat Wall Street estimates for second-quarter profit and revenue on Wednesday, boosted by strong demand for its services that help clients discover new drug ca...

6 weeks ago - Reuters

Charles River Laboratories Announces Second-Quarter 2023 Results

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CRL--Charles River Laboratories Announces Second-Quarter 2023 Results.

6 weeks ago - Business Wire

Charles River Laboratories International (CRL): A Significantly Undervalued Gem?

With a daily gain of 3.46% and an Earnings Per Share (EPS) of 9.67, Charles River Laboratories International Inc ( CRL , Financial) has presented an intriguing question to value investors: Is the stoc...

7 weeks ago - GuruFocus

Charles River Laboratories Expands Access to AAALAC-Accredited, Turnkey Research Space in Key Markets

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River announces the expansion of CRADL® in Seattle and Philadelphia, growing contract vivarium space for the biopharmaceutical industry.

7 weeks ago - Business Wire

Rathbone Funds Now Live on Charles River IMS® and State Street Alpha® Data Platform

LONDON--(BUSINESS WIRE)-- #assetmanagement--Charles River Development, a State Street Company, today announced that Rathbone Funds (Rathbone Unit Trust Management Ltd), the London-based subsidiary of ...

2 months ago - Business Wire

Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CRL--Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call.

2 months ago - Business Wire

CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders

NEW YORK , July 18, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Charles River Laboratories International, Inc. (NYSE: CR...

2 months ago - PRNewsWire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL

NEW YORK , July 17, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL). ...

2 months ago - PRNewsWire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Charles River Laboratories International, Inc. (CRL)

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming July 18, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors...

2 months ago - Business Wire

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Charles River Investors of a Lead Plaintiff Deadline of July 18, 2023

NEW YORK , July 17, 2023 /PRNewswire/ -- Attention Charles River Laboratories International, Inc. ("Charles River") (NYSE: CRL) shareholders: The Law Offices of Vincent Wong announce that a class acti...

2 months ago - PRNewsWire

Kessler Topaz Meltzer & Check, LLP Notifies Charles River Laboratories International, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit

RADNOR, Pa. , July 16, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been against Charles River L...

2 months ago - PRNewsWire

CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit

BENSALEM, Pa. , July 14, 2023 /PRNewswire/ -- Law Offices of Howard G.

2 months ago - PRNewsWire

CRL SHAREHOLDER ALERT: Jakubowitz Law Reminds Charles River Shareholders of a Lead Plaintiff Deadline of July 18, 2023

NEW YORK , July 14, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Charles River Laboratories International, Inc....

2 months ago - PRNewsWire

CRL LAWSUIT ALERT: Levi & Korsinsky Notifies Charles River Laboratories International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK , July 13, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Charles River Laboratories International, Inc. ("Charles River" or the "Company") (NYSE: CRL) of a class action sec...

2 months ago - PRNewsWire

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Charles River Laboratories International, Inc. - CRL

CEDARHURST, N.Y. , July 12, 2023 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Charles River Laboratories International, Inc. (NYSE: CRL)...

2 months ago - PRNewsWire